Skip to main content
. 2025 Jun 12;14(6):715. doi: 10.3390/antiox14060715
AD Alzheimer’s disease
AFLD alcoholic fatty liver disease
ALD alcoholic liver disease
AMPK AMP-activated protein kinase
APGS astaxanthin polyethylene glycol succinate
AST astaxanthin
AUC area under the curve
bw body weight
COPD chronic obstructive pulmonary disease
COX cyclooxygenase
CVD cardiovascular diseases
EMT epithelial–mesenchymal transition
FGF21 fibroblast growth factor 21
GPX glutathione peroxidase
HDL high-density lipoprotein cholesterol
HUVEC human umbilical vein endothelial cell
IL-6 interleukin-6
iNOS inducible nitric oxide synthase
LDL low-density lipoprotein cholesterol
LPS lipopolysaccharides
MAPK mitogen-activated protein kinase
MASLD metabolic dysfunction-associated steatotic liver disease
MCP-1 monocyte chemoattractant protein-1
mPTP mitochondrial permeability transition pore
NO nitric oxide
PD Parkinson’s disease
PEG polyethylene glycol
PGC-1α peroxisome proliferator-activated receptor gamma coactivator 1α
PLGA poly lactic-co-glycolic acid
PON1 paraoxonase 1
PPAR peroxisome proliferator-activated receptors
ROS reactive oxygen species
RNS reactive nitrogen species
SOD superoxide dismutase
SHR spontaneously hypertensive rat
STING Stimulator of Interferon Genes
TC total cholesterol
TNF-α tumor necrosis factor-alpha
VE-cadherin vascular endothelial cadherin